Market Cap 29.48M
Revenue (ttm) 0.00
Net Income (ttm) -4.52M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 1.72
Volume 283,300
Avg Vol 138,156
Day's Range N/A - N/A
Shares Out 442.60M
Stochastic %K 0%
Beta -0.66
Analysts Strong Buy
Price Target $4.00

Company Profile

Oncotelic Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of drugs for the treatment of orphan oncology indications in the United States. The company develops antisense and small molecule injectable drugs for the treatment of cancer. It is also developing OXi4503 for the treatment of acute myeloid leukemia and myelodysplastic syndromes; OT-101, an antisense against TGF-ß2, which is in phase 3 clinical trials for pancreatic cancer, melanoma, and glioblas...

Industry: Biotechnology
Sector: Healthcare
Phone: 650 635 7000
Fax: 650 635 7001
Address:
29397 Agoura Road, Suite 107, Agoura Hills, United States
twighttrades1
twighttrades1 Jul. 17 at 12:34 AM
$OTLC - this will be hot soon- they are puppeting this yes, but by no means are they happy with how things have gone- barely broke through a dime in recent highs- this is why i hold on- they have a bigger plan - thyll sell intonit but expect this next chapttto be large
1 · Reply
Bunster
Bunster Jul. 16 at 2:15 PM
$OTLC di prime just sell some shares to the ceo? hmm we shall see
0 · Reply
NetworkNewsWire
NetworkNewsWire Jul. 15 at 7:00 PM
BioMedNewsBreaks — $OTLC Brings AI and Robotics Together in New Platform https://ibn.fm/84daF
0 · Reply
NetworkNewsWire
NetworkNewsWire Jul. 9 at 8:03 PM
$OTLC Targets Biotech’s Manufacturing Bottleneck with AI-Powered GMP Platform https://ibn.fm/1aANC
0 · Reply
Techallure
Techallure Jul. 7 at 4:54 PM
$OTLC Question: How many Pharma stocks have issued tokens to shareholders ? That is a lot of blockchain movement just for the hell of it or was thoughtfully planned out many months ago as we near Clarity Act meetings
0 · Reply
NetworkNewsWire
NetworkNewsWire Jul. 7 at 4:41 PM
BioMedNewsBreaks — $OTLC Reports Positive Safety Review for Phase 1b Sapu003 Trial https://ibn.fm/sBbID
0 · Reply
InvitationW
InvitationW Jul. 7 at 4:00 PM
$OTLC — Oncotelic Successfully Completes Initial Safety Cohort of Phase 1b SP-03-B101 Trial; Independent Safety Review Committee Recommends Dose Escalation and European Expansion Underway https://finance.yahoo.com/healthcare/articles/oncotelic-successfully-completes-initial-safety-133000989.html
0 · Reply
Techallure
Techallure Jul. 7 at 2:27 PM
$OTLC More news … one can carry water to the donkeys but can’t force the rest.. Water is building up and rising …. Watch it … the dam will not withstand and hold the pressure There are a few story lines to be told here ..soon Enjoy
0 · Reply
ckruel
ckruel Jul. 7 at 2:11 PM
$OTLC Oncotelic Successfully Completes Initial Safety Cohort of Phase 1b SP-03-B101 Trial; Independent Safety Review Committee Recommends Dose Escalation and European Expansion Underway Oncotelic Therapeutics, Inc. Tue, July 7, 2026 at 8:30 AM CDT 7 min read
0 · Reply
CEOBuysDisclosures
CEOBuysDisclosures Jul. 2 at 9:05 PM
$OTLC CEO purchased 240,000 shares at $0.04 for a total of $10,344. Trieu Vuong now owns 117,777,232 shares. https://ceo-buys.com
0 · Reply
Latest News on OTLC
No data available.
twighttrades1
twighttrades1 Jul. 17 at 12:34 AM
$OTLC - this will be hot soon- they are puppeting this yes, but by no means are they happy with how things have gone- barely broke through a dime in recent highs- this is why i hold on- they have a bigger plan - thyll sell intonit but expect this next chapttto be large
1 · Reply
Bunster
Bunster Jul. 16 at 2:15 PM
$OTLC di prime just sell some shares to the ceo? hmm we shall see
0 · Reply
NetworkNewsWire
NetworkNewsWire Jul. 15 at 7:00 PM
BioMedNewsBreaks — $OTLC Brings AI and Robotics Together in New Platform https://ibn.fm/84daF
0 · Reply
NetworkNewsWire
NetworkNewsWire Jul. 9 at 8:03 PM
$OTLC Targets Biotech’s Manufacturing Bottleneck with AI-Powered GMP Platform https://ibn.fm/1aANC
0 · Reply
Techallure
Techallure Jul. 7 at 4:54 PM
$OTLC Question: How many Pharma stocks have issued tokens to shareholders ? That is a lot of blockchain movement just for the hell of it or was thoughtfully planned out many months ago as we near Clarity Act meetings
0 · Reply
NetworkNewsWire
NetworkNewsWire Jul. 7 at 4:41 PM
BioMedNewsBreaks — $OTLC Reports Positive Safety Review for Phase 1b Sapu003 Trial https://ibn.fm/sBbID
0 · Reply
InvitationW
InvitationW Jul. 7 at 4:00 PM
$OTLC — Oncotelic Successfully Completes Initial Safety Cohort of Phase 1b SP-03-B101 Trial; Independent Safety Review Committee Recommends Dose Escalation and European Expansion Underway https://finance.yahoo.com/healthcare/articles/oncotelic-successfully-completes-initial-safety-133000989.html
0 · Reply
Techallure
Techallure Jul. 7 at 2:27 PM
$OTLC More news … one can carry water to the donkeys but can’t force the rest.. Water is building up and rising …. Watch it … the dam will not withstand and hold the pressure There are a few story lines to be told here ..soon Enjoy
0 · Reply
ckruel
ckruel Jul. 7 at 2:11 PM
$OTLC Oncotelic Successfully Completes Initial Safety Cohort of Phase 1b SP-03-B101 Trial; Independent Safety Review Committee Recommends Dose Escalation and European Expansion Underway Oncotelic Therapeutics, Inc. Tue, July 7, 2026 at 8:30 AM CDT 7 min read
0 · Reply
CEOBuysDisclosures
CEOBuysDisclosures Jul. 2 at 9:05 PM
$OTLC CEO purchased 240,000 shares at $0.04 for a total of $10,344. Trieu Vuong now owns 117,777,232 shares. https://ceo-buys.com
0 · Reply
WallStreetSignals
WallStreetSignals Jul. 2 at 5:07 PM
$OTLC 📢 Biotech Update Oncotelic Therapeutics ($OTLC) has published a peer-reviewed manuscript supporting its Deciparticle™ nanoparticle delivery platform, reinforcing the scientific foundation behind Sapu003, its investigational IV everolimus formulation now in a Phase 1b study. Worth keeping on your biotech watchlist. https://www.globenewswire.com/news-release/2026/06/29/3318946/0/en/oncotelic-announces-peer-reviewed-validation-of-deciparticle-platform-supporting-clinical-development-of-sapu003.html #OTLC #BiotechStocks #DrugDevelopment #Nanomedicine #ClinicalResearch #InvestSmart #StockNews #TheBullRunShow
0 · Reply
Techallure
Techallure Jul. 2 at 1:12 PM
$OTLC back to .03 before news
0 · Reply
NetworkNewsWire
NetworkNewsWire Jun. 30 at 6:36 PM
From Hospitality to Pharma: TechForce Robotics Expanding Its Robotics-as-a-Service Platform into Laboratory Automation $NGTF $OTLC https://ibn.fm/0lbFE
0 · Reply
NetworkNewsWire
NetworkNewsWire Jun. 29 at 3:46 PM
BioMedNewsBreaks — $OTLC Publishes Peer-Reviewed Validation of Deciparticle(TM) Platform https://ibn.fm/QTopP
0 · Reply
WallStreetSignals
WallStreetSignals Jun. 29 at 3:29 PM
$OTLC Breaking News | Oncotelic Therapeutics, Inc. (OTCQB: #OTLC) has published a peer-reviewed manuscript validating its innovative Deciparticle™ nanoparticle platform. This follows the development of Sapu003, an investigational intravenous formulation of everolimus currently in a Phase 1b clinical trial, marking a significant step forward in therapeutic advancements. https://youtu.be/YC-47svVwLM #TheBullRunShow #OTLC #Oncotelic #OTCQB #ArtificialIntelligence #Robotics #Manufacturing #Biotech #HealthTech #AIStocks #GrowthStocks #SmallCaps #TrendingStocks #StockMarket #MarketNews #Innovation
0 · Reply
Techallure
Techallure Jun. 29 at 2:55 PM
$OTLC Deciparticle platform The platform that will become a necessity to see any progress in many a pipeline.
0 · Reply
Techallure
Techallure Jun. 28 at 8:25 PM
$OTLC A parlay played with the joined technology of Roivant type companies and Oncotelic type companies makes all the difference and reduces the risk of failure to zero I ANTicipate some news forthcoming … who knows
0 · Reply
ckruel
ckruel Jun. 25 at 8:03 PM
$OTLC Insiders bought 25k dollar value in shares last qtr.
0 · Reply
CEOBuysDisclosures
CEOBuysDisclosures Jun. 25 at 2:40 AM
$OTLC CEO purchased 255,000 shares at $0.04 for a total of $11,475. Trieu Vuong now owns 117,537,232 shares. https://ceo-buys.com
0 · Reply
NetworkNewsWire
NetworkNewsWire Jun. 24 at 6:05 PM
NetworkNewsBreaks – $OTLC Eyes Opportunity Through AI and Pharmaceutical Automation https://nnw.fm/jtydH
0 · Reply
Techallure
Techallure Jun. 23 at 4:32 PM
$OTLC and $RDGL A power packed $1-$2 punch Be prepared Bein.. repaired
6 · Reply
NetworkNewsWire
NetworkNewsWire Jun. 23 at 4:26 PM
The $410 Billion Drug Delivery Revolution: Why Drug Delivery May Be the Next Major Frontier in Oncology Innovation $OTLC https://ibn.fm/EImJf
0 · Reply